Versiti acquires Texas-based Cenetron Central Laboratories and Salus IRB to advance clinical trial capabilities
Milwaukee, Wisconsin, July 12, 2019 – Versiti, a national leader in blood health innovation, today announced the acquisition of Texas-based Cenetron Central Laboratories, and its subsidiary, Salus IRB, offering both organizations the opportunity to expand clinical trial services and expertise.
Salus IRB Announces Name Change
Austin, Texas, March 10, 2014 – RCRC IRB announced today that its organization has changed its name to Salus IRB. The management, administrative staff, ownership structure, and review board memberships remain unchanged.
Salus IRB Announces Addition of Third Review Board
Austin, Texas, September 02, 2013 – RCRC IRB announced today that it has added an additional review board for continued customer service enhancement. Alexander Kenaston chairs the additional board. Dr. Kenaston has over ten years’ experience in the IRB and research fields. Dr. Jennifer Christensen, a previous researcher, is the vice-chair of the new board. Both Dr. Kenaston and Dr. Christensen have experience serving on academic institutional IRBs and commercial or independent IRBs.